Literature DB >> 1840645

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine.

H H Van Tol1, J R Bunzow, H C Guan, R K Sunahara, P Seeman, H B Niznik, O Civelli.   

Abstract

Dopamine receptors belong to the family of G protein-coupled receptors. On the basis of the homology between these receptors, three different dopamine receptors (D1, D2, D3) have been cloned. Dopamine receptors are primary targets for drugs used in the treatment of psychomotor disorders such as Parkinson's disease and schizophrenia. In the management of socially withdrawn and treatment-resistant schizophrenics, clozapine is one of the most favoured antipsychotics because it does not cause tardive dyskinesia. Clozapine, however, has dissociation constants for binding to D2 and D3 that are 4 to 30 times the therapeutic free concentration of clozapine in plasma water. This observation suggests the existence of other types of dopamine receptors which are more sensitive to clozapine. Here we report the cloning of a gene that encodes such a receptor (D4). The D4 receptor gene has high homology to the human dopamine D2 and D3 receptor genes. The pharmacological characteristics of this receptor resembles that of the D2 and D3 receptors, but its affinity for clozapine is one order of magnitude higher. Recognition and characterization of this clozapine neuroleptic site may prove useful in the design of new types of drugs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1840645     DOI: 10.1038/350610a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  295 in total

1.  Cognition, schizophrenia, and the atypical antipsychotic drugs.

Authors:  H Y Meltzer; S Park; R Kessler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  D4 dopamine and metabotropic glutamate receptors in cerebral cortex and striatum in rat brain.

Authors:  M A Berger; M C Defagot; M J Villar; M C Antonelli
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

Review 3.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

4.  Dopamine D4 receptor-deficient mice display cortical hyperexcitability.

Authors:  M Rubinstein; C Cepeda; R S Hurst; J Flores-Hernandez; M A Ariano; T L Falzone; L B Kozell; C K Meshul; J R Bunzow; M J Low; M S Levine; D K Grandy
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

5.  A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons.

Authors:  D Lévesque; M P Martres; J Diaz; N Griffon; C H Lammers; P Sokoloff; J C Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Dopamine D4 Receptors Regulate GABAA Receptor Trafficking via an Actin/Cofilin/Myosin-dependent Mechanism.

Authors:  Nicholas M Graziane; Eunice Y Yuen; Zhen Yan
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

7.  Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.

Authors:  J E Leysen; W Gommeren; J Mertens; W H Luyten; P J Pauwels; M Ewert; P Seeburg
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat.

Authors:  E L Gardner; L S Walker; W Paredes
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.

Authors:  H Lublin; J Gerlach; L Peacock
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Identification of novel catecholamine absorbing proteins in the central nervous system.

Authors:  G M Ross; B E McCarry; S Thakur; R K Mishra
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.